Vyvgart brought us back to life (Ellie)
- Condition
- Long COVID
- At worst
- Severe (mostly bedbound)
- Ill for
- Not stated
- Published
- Oct 2025
Summary
Ellie also received Vyvgart (efgartigimod) in the trial, with no specific dose described. A geologist previously limited by severe Long COVID symptoms, she improved enough on the drug to resume field work without fearing she would pass out. The article does not say whether this benefit continued after the trial ended.
What they credit
Credits Biologics & antibodies, Efgartigimod / Vyvgart.
Similar stories
-
Vyvgart brought us back to life (Clare)
Clare, a nurse previously unable to work because of Long COVID, received Vyvgart (efgartigimod) in the trial, with no specific dose stated, and it significantly improved her tachycardia and lessened her post-exertional malaise. After the trial ended, her…
-
Vyvgart brought us back to life (Michaelene)
Michaelene was on Vyvgart (efgartigimod) for five months in the trial's open-label phase and had improved enough that she no longer met criteria for POTS when the trial was abruptly canceled. She had been severely disabled before treatment. After the trial…
-
Vyvgart brought us back to life (Mia)
Mia Delli Gatti took part in the same Vyvgart (efgartigimod) trial, though the article gives no specific dose or schedule for her. As a college student, Long COVID had previously left her unable to maintain a full course load, but on the drug she was able to…
-
Vyvgart brought us back to life (Nicole)
Nicole Barrick, a nurse who contracted COVID while working on a COVID unit, received weekly Vyvgart (efgartigimod) infusions, and after six months in the trial's open-label phase she no longer met the clinical criteria for POTS on tilt-table testing, with…